Is QLIS or MRK a better dividend investment in 2026?

QLIS currently yields 749.91% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: QLIS offers higher current income.

What is the dividend yield difference between QLIS and MRK?

QLIS has a forward dividend yield of 749.91% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 746.66 percentage points.

Home › Compare › QLIS vs MRK

QLIS vs MRK: Dividend Comparison 2026

QLIS yields 749.91% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QLIS wins by $1610827.78M in total portfolio value

INVESTMENT

TIME HORIZON10 years

QLIS

● Live price

749.91%

Share price

$0.27

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1610827.81M

Annual income

$1,276,085,525,866.60

Full QLIS calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — QLIS vs MRK

📍 QLIS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QLIS	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QLIS + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QLIS pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QLIS

Annual income on $10K today (after 15% tax)

$63,742.03/yr

After 10yr DRIP, annual income (after tax)

$1,084,672,696,986.61/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, QLIS beats the other by $1,084,672,696,178.86/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QLIS + MRK for your $10,000?

QLIS: 50%MRK: 50%

100% MRK50/50100% QLIS

Portfolio after 10yr

$805413.92M

Annual income

$638,042,763,408.45/yr

Blended yield

79.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

QLIS

No analyst data

Altman Z

119.3

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QLIS buys

MRK buys

No recent congressional trades found for QLIS or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQLISMRK

Forward yield	749.91% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$1610827.81M ✓	$30.7K
Annual income after 10y	$1,276,085,525,866.60 ✓	$950.29
Total dividends collected	$1584060.32M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: QLIS vs MRK ($10,000, DRIP)

Year	QLIS Portfolio	QLIS Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$85,691	$74,990.63	$11,192	$351.54	+$74.5K → QLIS
2	$692,249	$600,560.16	$12,524	$392.70	+$679.7K → QLIS
3	$5,274,919	$4,534,212.22	$14,015	$438.65	+$5.26M → QLIS
4	$37,934,414	$32,290,251.30	$15,682	$489.96	+$37.92M → QLIS
5	$257,612,569	$217,022,745.57	$17,547	$547.23	+$257.60M → QLIS
6	$1,653,029,786	$1,377,384,337.07	$19,632	$611.16	+$1653.01M → QLIS
7	$10,028,835,936	$8,260,094,064.96	$21,963	$682.53	+$10028.81M → QLIS
8	$57,565,912,498	$46,835,058,046.16	$24,571	$762.18	+$57565.89M → QLIS
9	$312,843,259,302	$251,247,732,929.55	$27,486	$851.08	+$312843.23M → QLIS
10	$1,610,827,813,320	$1,276,085,525,866.60	$30,745	$950.29	+$1610827.78M → QLIS

QLIS vs MRK: Complete Analysis 2026

QLIS — Stock

Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. The company is headquartered in Chadds Ford, Pennsylvania.

Full QLIS Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this QLIS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QLIS vs SCHD QLIS vs JEPI QLIS vs O QLIS vs KO QLIS vs MAIN QLIS vs JNJ QLIS vs ABBV QLIS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.